key: cord-0985693-gfb2d1ge
authors: Wang, Le; Diwu, Wenbo; Tan, Nana; Wang, Huan; Hu, Jingbo; Xu, Bailu; Wang, Xiaoling
title: Pathway‐based protein–protein association network to explore mechanism of α‐glucosidase inhibitors from Scutellaria baicalensis Georgi against type 2 diabetes
date: 2021-04-26
journal: IET Syst Biol
DOI: 10.1049/syb2.12019
sha: 18de21b13eab45c2100e24e2fcc15c8e5109879d
doc_id: 985693
cord_uid: gfb2d1ge

Natural products have been widely used in the treatment of type 2 diabetes (T2D). However, their mechanisms are often obscured due to multi‐components and multi‐targets. The authors constructed a pathway‐based protein–protein association (PPA) network for target proteins of 13 α‐glucosidase inhibitors (AGIs) identified from Scutellaria baicalensis Georgi (SBG), designed to explore the underlying mechanisms. This network contained 118 nodes and 1167 connections. An uneven degree distribution and small‐world property were observed, characterised by high clustering coefficient and short average path length. The PPA network had an inherent hierarchy as C(k)∼k (−0.71). It also exhibited potential weak disassortative mixing pattern, coupled with a decreased function Knn (k) and negative value of assortativity coefficient. These properties indicated that a few nodes were crucial to the network. PGH2, GNAS, MAPK1, MAPK3, PRKCA, and MAOA were then identified as key targets with the highest degree values and centrality indices. Additionally, a core subnetwork showed that chrysin, 5,8,2′‐trihydroxy‐7‐methoxyflavone, and wogonin were the main active constituents of these AGIs, and that the serotonergic synapse pathway was the critical pathway for SBG against T2D. The application of a pathway‐based protein–protein association network provides a novel strategy to explore the mechanisms of natural products on complex diseases.

The global incidence of type 2 diabetes (T2D) in adults is increasing worldwide [1] . It is a complex disease affected by many factors and complications. In 2020, a detrimental effect of T2D on COVID-19 was also found [2] . The treatment and management of T2D is becoming increasingly complex [3] , and natural products have been considered as the main sources of new drugs [4] . Recently, increasing numbers of natural products have been found to have anti-T2D properties [5] . Some have been widely used to control diabetes, such as curcumin, flavanone, resveratrol, carotenoid, and polyphenols [6] . The α-glucosidase inhibitors (AGIs) are described as the most effective anti-diabetic drugs in the management of T2D [7] . They can suppress the postprandial blood glucose and insulin levels. Many α-glucosidase inhibitors originate from natural products, especially phytoconstituents [8] .

Flavonoids are a group of polyphenols, and are widely distributed in plants [9] . Flavonoids could modulate the activity of enzymes and affect the behaviour of cell systems [10] . A series of flavonoids show antidiabetic properties and activities in the treatment of diabetic complications, including apigenin, hesperidin, catechin, etc. [11] . Some are considered as promising AGIs, such as luteolin, isovitexin, and quercetin [7] .

Scutellaria baicalensis Georgi (SBG) is a widely used medical plant in Asia [12] . Flavonoids and their glycosides are considered to be characteristic components of SBG [13] . Extract of this plant has been reported to show an α-glucosidase inhibition activity [5] . In the authors' previous works [14] , a total of 32 flavonoids from the root of SBG were extracted and identified. Moreover, 13 of them were exhibited as α-glucosidase inhibitors, including wogonin, chrysin, and oroxylin A, etc. Their contributions to the bioactivities of SBG were also investigated. However, more works should be done to elucidate the molecular mechanisms of these flavonoids against T2D.

Interactions between individual agents determine the structures and functions of many biological systems [15] . It is noteworthy that the associations between target proteins contribute much to modulate cellular physiology and expand the opportunity for drug discovery [16] . The protein-protein interaction profiles are extremely important to the pharmacological effects of natural products [17] . Nevertheless, systematic analyses of these interrelationships are still challenging tasks. One of the primary reasons for this is that natural products have chemical diversity and the ability to interact with multi-targets [18] . To fully understand their pharmacological effects, it is vital to explore the associations between all the target proteins for bioactive constituents in natural products [19] . Additionally, a global methodology is needed to extract the related active constituents and biological pathways.

In recent years, complex network theory has been applied to the drug development strategies [20] . It is also known as 'network pharmacology' or 'system pharmacology' in the research into natural products [21] . This approach aims to pick up information from big data, and summarise rules of individual parts. It is suitable for extracting biological information from large amounts of chemical or biological data [22] . Many studies have applied complex network methodology to investigate the therapeutic potential of natural products [23] . For instance, a network pharmacology-based analysis found that Rhizoma coptidis played an anti-diabetic role mainly via hormone receptor activity, glutathione binding, steroid binding, etc. [24] . Another study constructed a component/target/pathway network for Rhizoma coptidis against T2D, and 12 active components, 57 targets, as well as 38 signalling pathways were screened [25] . It suggested significant potential of this tool in predicting pharmacological actions of active ingredients from medicinal plants against T2D. Guo et al. applied the network methodology to explore the effects of Gynura procumbens (Lour.) on T2D, and revealed that the PI3K/Akt signalling pathway played a momentous role [26] . Patil et al. investigated the molecular mechanisms of action of 11 common herbs used for the management of T2D, using molecular docking, gene set enrichment analysis, and network pharmacology [27] . The network analysis results showed that the PI3K-AKT signalling pathway was a key pathway of T2D and its complications that was modulated by the phytoconstituents. In summary, the emerging tool of a complex network would greatly contribute to drug discovery.

Herein, the authors used a complex network model to investigate the underlying mechanisms of AGIs from SBG against T2D. Target proteins of these AGIs were organised into a pathway-based protein-protein association (PPA) network. The network architectures were studied in a systematic manner. Statistical and topological analyses were performed to investigate the interrelationships between nodes. Furthermore, a series of parameters were calculated to identify key nodes in the network, which indicated the main active constituents, key targets and critical biological pathways for the AGIs from SBG against T2D.

In the authors' previous studies [14] , 13 α-glucosidase inhibitors (AGIs) were identified from SBG by ultrafiltration LC-MS method, including tenaxin I, skullcapflavone II, viscidulin III, etc. Detailed information about these compounds is listed in Table S1 . They were organised as a chemical ingredients database for the next network analysis.

Target proteins of the AGIs were collected from SuperPred (http://prediction.charite.de/) and DrugBank (https://www. drugbank.ca/). Target prediction for the input compounds was also performed by SuperPred, based on the similarity distribution among ligands [28] . Information of these proteins was made uniform by the universal protein resource (Uniprot, http://www.uniprot.org/). Pathway analysis was applied to these target proteins using the Database for Annotation and Integrated Discovery (DAVID 6.8, https://david.ncifcrf.gov/). Raw p-values were adjusted with the Benjamini & Hochberg procedure (p < 0.05) [29] . Moreover, the pathways containing only one or two proteins were excluded from the results. An association was established between two proteins if they were both involved in one or more pathways.

Complex network methodology was employed to study the interrelationships between the target proteins of AGIs from SBG. A pathway-based protein-protein association network was then constructed. The PPA network contained many nodes and edges, in which nodes referred to the target proteins, and edges represented associations between nodes. This network was visualised by Pajek (Version 5.1, Batagelj and Mrvar). A set of parameters were investigated for further interpretation of the PPA network, using MATLAB 2016a (The MathWorks Inc.).

A total of 13 potential AGIs were identified from SBG by ultrafiltration UPLC-Q-TOF in the authors' previous experiments. These compounds were organised as a chemical ingredients database (Table S1) , containing viscidulin III, chrysin-7-O-β-D-glucopyranoside, skullcapflavone II, 2 0 ,6 0 ,7trihydroxy-5-methoxyflavanone, etc. Herein, a series of 118 targets were collected using web tools (Table S2 ). Parts of these proteins were therapeutic targets of T2D [30] , such as glucocorticoid receptor, peroxisome proliferator-activated receptor delta, poly(ADP-ribose) polymerase 1, etc. Numerous targets suggested that AGIs from SBG were involved in various signal pathways.

A pathway contains a set of cascade reactions among numerous biomolecules. It regulates various biological functions in the organism. The target proteins of AGIs from SBG were involved in 86 pathways (Table S2) , including the oestrogen signalling pathway, ascorbate and aldarate metabolism, thyroid hormone signalling pathway, pentose and glucuronate interconversions, etc. Abnormal pathways mean perturbations in the intracellular or intercellular network between tissues and organs.

Interactions between target proteins are one of the core processes for the effects of natural products on cells. A pathway-based protein-protein association network was then constructed to investigate interrelationships for targets of AGIs. This network has 118 nodes (N = 118) and 1167

connections (E = 1167). As shown in Figure 1 , a few nodes were highly connected with others, whereas many others were less connected or even isolated. This indicated that the nodes had different significances in PPA network. The authors made further investigation of the topological parameters of the PPA network to explore the behaviours of these target proteins.

The global properties of systems are always determined by the overall framework rather than individual parts. A complex network provides an approach to get information by calculating the network parameters, which contain lots of biological information, and could help to interpret the network locally [31] . 

N is the total number of nodes in the PPA network, and d ij is the shortest path length from a node i to j. The connected components of the PPA network showed a very short average path length (L = 1.92), smaller than a random network with the same amount of nodes. Additionally, the diameter of this network was 4. This meant that there were at most four links between any pair of nodes. Therefore, target proteins of AGIs from SBG appeared to be tightly linked with each other. This further confirmed that the α-glucosidase inhibitors from SBG worked through multi-targets.

The clustering coefficient reflects the cohesiveness of neighbours for a node, which measures the trend of nodes to form connected triangles. C of a node i (C i ) is displayed below:

This parameter goes from zero to one. When C i inclines to zero, the node is among the unintegrated clusters or part of a loosely connected group. Conversely, the node is centred in a highly interconnected cluster. The clustering coefficient of the whole network (C) is the average C i of all nodes. It shows the trend of nodes to be involved in clusters. C(k) reflects the distribution of clustering coefficient for all the nodes.

The clustering coefficient of the PPA network was 0.83. It showed a strong tendency of these proteins to form clusters. The distribution of C i was analysed in Figure 2 . Apparently, most of the non-isolated nodes had a high C i value that was larger than 0.5. It was probable for these nodes to be involved in a more connected cluster, indicating that a critical pathway existed for the bioactivities of α-glucosidase inhibitors from SBG.

Many networks in the real world are either completely regular or completely random. However, the PPA network demonstrated a small-world property, characterised by a high clustering coefficient and short average path length [32] . This suggested that the network was composed of many small, closely linked, hierarchical clusters, and presented as large, less cohesive cells. Disturbances on a few key nodes would diffuse rapidly into the whole network. In other words, a small number of key targets were crucial to the bioactivities of α-glucosidase inhibitors from SBG. This feature also existed in many other biological networks [33] .

C(k) was evaluated and fitted in Figure 3 . It showed a power-law decay with an exponent of 0.71, C(k)∼k −0.71 . The PPA network appeared as a hierarchical system for the nonuniform, power-law of C(k). It indicated that many nodes tended to be involved in heavily connected regions, which produced a higher clustering coefficient of the network. In other words, many targets of AGIs were strongly connected, and simultaneously belonged to a few pathways. These interconnections might play an important part in the pharmacological effects of AGIs from SBG.

Degree (k) is one of the most important characteristics for a node. The number of direct links for node i is defined as k i . The mean value of all k i is the average degree 〈k〉 of the network. The nodes with the most links are defined as hubs of the network. Degree distribution, represented as P(k), describes the proportion of nodes with a particular number of links.

where e ij is the number of links from node i to j. Degree correlation measures the influence of connectivity for a node on its neighbours [34] . Degree correlations of the network are represented as the average nearest neighbours degree K nn,i for node i. K nn (k) indicates K nn of nodes with a degree k. -129

The network is either assortative or disassortative, determined by K nn (k) is increasing or decreasing as a function of k. If no correlation exists among all nodes, K nn (k) is 0.

The assortativity coefficient (r) measures degree correlations between neighbours in a network [35] . If r is a positive value, the network is assortative, otherwise it is disassortative with a negative value of r.

The average nearest neighbours degree, K nn (k) of the PPA network is shown in Figure 4 . It is exhibited as a decreasing function of k, as well as a potential weak disassortative mixing (k > 10). The assortativity coefficient (r) of the PPA network was −0.1, showing the same trend as K nn . This illustrated that interactions might exist between nodes with large degrees and small degrees. Many biological networks are also inclined to be disassortative [36] . This might be the result for the highly complex constitution of organisms.

Numerous nodes in the network have different responsibilities. Degree distribution P(k) reflects the diversity of a network. The numbers and frequencies of different degree values are listed in Table 1 .

The PPA network showed an uneven degree distribution. A part of nodes was isolated or had small degrees less than 10, whereas that of a few nodes were larger than 50. Average degree 〈k〉 of the PPA network was 19.76, implying that an average of nearly 20 targets appeared in common pathways.

The most highly connected nodes are defined as hubs. All nodes were sorted according to degree values ( Figure 5 ). Among the 118 targets of AGIs from SBG, prostaglandin G/H synthase 2 precursor (PGH2) had the highest degree of 63, then mitogenactivated protein kinase 1 (MAPK1, k = 53), mitogen-activated protein kinase 3 (MAPK3, k = 53), guanine nucleotide-binding protein G(s) subunit alpha (GNAS, k = 51) and protein kinase C alpha type (PRKCA, k = 51). The five proteins showed much higher degree values than the average (〈k〉 = 19.76), and were considered as hub nodes of the PPA network. Hubs are always located to determine the network function [32] . Larger degrees demonstrated that these targets had larger impacts on the network. Although natural products had many target proteins, the highly connected ones involved in various pathways might contribute most to the pharmacological effects.

Centrality demonstrates the relative influence of a node on the network structure. Three centrality indices (CI), degree centrality (C d ), betweenness centrality (C b ), and closeness centrality (C c ) are evaluated to search central nodes of the PPA network. C d indicates the proportion of other nodes adjacent to a node. C b is the total quantity of the shortest paths through a node. C c is the quantity of other nodes divided by the sum of distances between one node and all the others. The equations are as follows: 

where g jk is the number of geodesics connecting nodes j and k, and d ij is the shortest path length between nodes i and j.

The central locations of a network are more important than marginal or isolated positions [37] . The central nodes of the PPA network were investigated by three indexes. Figure 6 is a 3D graph illustrating the distribution of CI. Figure 6 . Detailed data of CI are listed in Table S3. 

The six central nodes were located in key positions of the PPA network. A total of 70 neighbours were directly linked to them. These target proteins accounted for 59.3% of all nodes, and were involved in common pathways with the central nodes. Moreover, five of the central nodes were also hubs of the PPA network. High connectivity and centrality suggested that disturbances to the six proteins would spread rapidly throughout the whole network. Therefore, they were considered as key targets for the AGIs from SBG.

Recent studies have demonstrated the association between these key targets and T2D. PGH2 generates prostaglandins and causes insulin insensitivity. PGH2 polymorphisms were found to play a role in mediating susceptibility to T2D in Pima Indians [38] . The GNAS gene encodes the heterotrimeric Gs protein α-subunit. It is an important regulator of insulin secretory capacity in pancreatic β-cells [39] . MAPK1 and MAPK3 belong to the MAPK/ERK cascade, which could affect insulin signalling [40] . They are increased in human and rodent adipose tissue in diabetic states [41] . PRKCA encodes a cytoplasmic serine/threonine kinase. Variants in PRKCA are significantly associated with diabetes [42] . MAOA is a critical regulator of neurotransmitter signalling at monoaminergic synapses. Polymorphisms in MAOA were found to be associated with obesity, a key factor contributing to the incidence of [43] . These reports further confirmed the importance of the key targets in the treatment of T2D.

T2D is a complex disease regulated by a group of pathways [44] . Accordingly, the mechanism of AGIs from SBG in T2D is confused. Although the number of key targets was small, these proteins played a significant part in the pharmacological effect of AGIs. To enhance the interpretation, the key targets together with related AGIs, pathways were extracted. These data were then integrated into a core subnetwork, containing 10 nodes and 15 connections (Figure 7) .

These nodes had significant impacts on the global function of the PPA network. The node information is listed in Table 2 .

Three AGIs showed direct associations with the key targets, including chrysin, 5,8,2 0 -trihydroxy-7-methoxyflavone, and wogonin. They were considered as the main active constituents. Chrysin is a natural component extracted mainly from plants. It has been demonstrated to have a potent antidiabetogenic effect. Chrysin could improve diabetes in streptozotocin-induced diabetic rats [45] . This compound was also found to ameliorate diabetes-associated cognitive deficits in Wistar rats [46] . Wogonin has been shown to be effective in controlling diabetes and its complications. It could increase GLUT4 (Glucose transporter 4) trafficking to plasma membrane, which allows increased entry of glucose and thus alleviates hyperglycaemia [47] . The three AGIs from SBG are all flavonoids. Bioactivities of flavonoids are dependent on the hydroxylated phenolic structure [48] . Although the reports about pharmacological action of 5,8,2 0 -trihydroxy-7-methoxyflavone are few, it has a potential antidiabetogenic effect, which should be tested in the future. These main active constituents might contribute most to the pharmacological effects of AGIs from SBG.

All six key targets were involved in the serotonergic synapse pathway (hsa04726). It was exhibited as a critical pathway for SBG and T2D ( Figure 8 ). The regulating effects of natural products against T2D are based on various targets and signal pathways [5] . The serotonergic synapse pathway is mainly related to the nervous system, and T2D is a systemic disorder affected by both the central and peripheral nervous systems [49, 50] . Serotonin, also known as 5hydroxytryptamine (5-HT), is a monoamine neurotransmitter. It plays a significant role in many major risk factors for T2D, such as obesity, glucose control, and insulin resistance [51] . Serotonin was reported to control the glucose homeostasis of the nervous system [52] . The serotonin transporter was found to play a potential role in antidepressant-induced type 2 diabetes [53] . Moreover, serotonin 2C receptor agonists could increase glucose tolerance and improve T2D [54] . Recent research has also identified genetic markers involved in the serotonergic synapse pathway and T2D using a systems biology approach [55] . These reports supported the hypothesis that the αglucosidase inhibitors from SBG contributed to control T2D through the serotonergic synapse pathway, which needs to be confirmed in future studies. 

Natural products are characterised by multi-components and multi-targets, which cause difficulties in the mechanism research [56] . The complex network method enables the extraction of information from protein-protein interactions data, and is suitable for exploring the underlying mechanism from a system point of view. Most studies into proteinprotein interactions of natural products used major public databases as data sources. For instance, Hu et al. built a human protein-protein interaction network and the T2D disease protein interaction network [57] , designed to provide new effective combinations of herbal medicines for T2D. The data were collected from seven databases, including Bio-GRID, BIND, DIP, HPRD, iRefWeb, IntAct, and MINT. Ren et al. constructed a protein-protein interaction network for Anshen essential oil based on the STRING database, and found that SLC4A4 was in the centre of the targets, followed by HTR3A, HTR2A, DRD2, etc. [58] . In the authors' previous works [14] , they conducted a network analysis of the targets of AGIs from SBG and that of commercial drugs for T2D. The interaction data were also calculated by the STRING database. These data mainly originated from experimental data and literature, which focussed on the interrelationships between each pair of proteins. On the other hand, large amounts of targets of natural products are involved in a series of pathways in vivo, and therapeutic effects of natural products are achieved through these signalling pathways [59, 60] . Thus, more attention should be paid to protein interactions based on common pathways. This study aimed to explore mechanisms of AGIs from SBG against T2D using a pathway-based protein-protein association network, which would provide more information from a system point of view. Hub nodes of this network were analysed and extracted, and were considered as key targets, main active constituents, as well as critical pathways for AGIs from SBG. These results were also supported by previous reports.

However, some important issues to be addressed include that more computational models and experiments are needed to prove these results.

In the study discussed herein, a pathway-based proteinprotein association network was built for target proteins of α-glucosidase inhibitors from Scutellaria baicalensis Georgi. This network showed a series of distinct features, such as uneven degree distribution and small-world property, an inherent hierarchy as C(k)∼k −0.71 , as well as potential weak disassortative mixing pattern, coupled with decreased function K nn (k) and negative value of assortativity coefficient. These data indicated that the network was greatly affected by a small group of components. PGH2, GNAS, MAPK1, MAPK3, PRKCA, and MAOA were then selected as key targets of these AGIs. The serotonergic synapse was found to be a critical pathway for the AGIs from SBG against T2D. These conclusions are also strongly supported by previous reports. Generally, the application of a complex network would expand the authors' views on natural products in the treatment of T2D.

Diabetic kidney disease in patients newly diagnosed with type-2 diabetes mellitus: incidence and associations

Managing type 2 diabetes mellitus during Covid-19 pandemic: the bittersweet

Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus

The strategies and techniques of drug discovery from natural products

Natural products for the treatment of type 2 diabetes mellitus: pharmacology and mechanisms

Natural products in diabetes research: quantitative literature analysis

α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure-activity relationship study

A replication study of the IRS1, CAPN10, TCF7L2, and PPARG gene polymorphisms associated with type 2 diabetes in two different populations of Mexico

Dietary flavonoids in the prevention of T2d: an overview

Flavonoids: old and new aspects of a class of natural therapeutic drugs

Antidiabetic potential of flavonoids from traditional Chinese medicine: a review

Identification of Scutellaria baicalensis in traditional Chinese medicine preparations by Lc/Ms/Ms fingerprinting method

Lamiaceae): a review of its traditional uses, botany, phytochemistry, pharmacology and toxicology

Metabolomics analysis of laparoscopic surgery combined with Wuda granule to promote rapid recovery of patients with colorectal cancer using UPLC/Q-TOF-MS/MS. Evid. Base Compl

Modelling complex biological systems using an agent-based approach

Inducing protein-protein interactions with molecular glues

Stabilisation of protein-protein interactions in drug discovery

Exploring natural products as a source for antidiabetic lead compounds and possible lead optimization

The comprehensive screening of traditional Chinese medicine using a novel Lc/Ms informatics platform

Integrative approaches for finding modular structure in biological networks

Network pharmacology: the next paradigm in drug discovery

Chemo-and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review

Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products

Network pharmacology-based analysis of effective components and mechanism of Rhizoma coptidis in treating diabetes

Active ingredients and mechanism of action of Rhizoma coptidis against type 2 diabetes based on network-pharmacology and bioinformatics

Exploring the protective effect of Gynura procumbens against type 2 diabetes mellitus by network pharmacology and validation in C57bl/Ksj Db/Db Mice

Gene set enrichment analysis, network pharmacology and in silico docking approach to understand the molecular mechanism of traditional medicines for the treatment of diabetes mellitus

Superpred: update on drug classification and target prediction

Controlling the false discovery rate: a practical and powerful approach to multiple testing

Current strategies and drug targets in the management of type 2 diabetes mellitus

Network-based approaches in pharmacology

Network hubs in the human brain

Spatiotemporal behaviour of small-world neuronal networks using a map-based model

Sampling networks with prescribed degree correlations

Assortativity in complex networks

Emergence of disassortative mixing from pruning nodes in growing scale-free networks

Reconstruction and analysis of correlation networks based on Gc-Ms Metabolomics data for Young Hypertensive men

Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians

GNAS gene is an important regulator of insulin secretory capacity in pancreatic β-cells

Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (Irs) serine phosphorylation

Mitogen-activated protein kinases, inhibitory-κB kinase, and insulin signalling in human Omental versus Subcutaneous adipose tissue in obesity

The link between low back pain and diabetes: gene-based association study in people with comorbid diabetes mellitus and low back pain

Association of polymorphisms in 5-Htt (Slc6a4) and Maoa genes with measures of obesity in young adults of Portuguese origin

State of the art paper central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns

Chrysin treatment improves diabetes and its complications in liver, brain, and pancreas in streptozotocin-induced diabetic rats. Can

Chrysin ameliorates diabetes-associated cognitive deficits in Wistar rats

Wogonin alleviates hyperglycemia through increased glucose entry into cells via Akt/Glut4 pathway

Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships

Obesity, diabetes and the central nervous system

Diabetes and the nervous system

Prevalence of obesity, diabetes, and obesity-related health risk factors

Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes

Role of serotonin transporter in antidepressantinduced diabetes mellitus: a pharmacoepidemiologicalpharmacodynamic study in VigiBase

Serotonin 2c receptor agonists improve type 2 diabetes via melanocortin-4 receptor signalling pathways

A systems biology approach to identifying genetic markers that link progression of Parkinson's disease to risk factors related to ageing, lifestyle and type 2 diabetes

Current computational methods for predicting protein interactions of natural products

Design of new traditional Chinese medicine herbal formulae for treatment of type 2 diabetes mellitus based on network pharmacology

The mechanism of compound Anshen essential oil in the treatment of insomnia was examined by network pharmacology

Modulation of multiple signalling pathways of the plantderived natural products in cancer

Cellular signalling perturbation by natural products

The authors declare no conflicts of interest.